TNAX Biopharma

About:

TNAX Biopharma is a biopharmaceutical company that offers the development and commercialization of novel antibody therapeutics drugs.

Website: https://tnaxbio.com/

Top Investors: Mitsubishi UFJ Capital, JAFCO, Nissay Capital

Description:

TNAX Biopharma is a developer of pharmaceuticals drugs intended to improve the quality of life of patients.The company provides novel antibody therapeutics for unmet medical needs of patients with intractable diseases, thus providing patients therapeutics around the world through drug discovery innovation.

Total Funding Amount:

999M JPY

Estimated Revenue Range:

$10B+

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2018-01-01

Founders:

Shibuya Akira, Tak Mukohira

Number of Employees:

101-250

Last Funding Date:

2019-11-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai